Praveen P. Tipirneni Morphic Holding, Inc. (MORF) insider trading activity

Praveen P. Tipirneni is President and CEO of Morphic Holding, Inc.. Currently has a direct ownership of 0 shares of MORF, which is worth approximately $0. The most recent transaction as insider was on Aug 16, 2024, when has been sold 42,460 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Praveen P. Tipirneni Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 16 2024	SELL Disposition due to a tender of shares in a change of control transaction	-	42,460 Reduced 100.0%	0 Common Stock
Jul 08 2024	SELL Open market or private sale	$1,204,059 $55.79 p/Share	21,582 Reduced 33.7%	42,460 Common Stock
Jul 08 2024	BUY Exercise of conversion of derivative security	$93,234 $4.32 p/Share	21,582 Added 25.21%	64,042 Common Stock
Jan 16 2024	SELL Open market or private sale	$382,743 $27.49 p/Share	13,923 Reduced 24.89%	42,013 Common Stock
Jan 14 2024	BUY Exercise of conversion of derivative security	-	12,500 Added 18.27%	55,936 Common Stock
Jan 13 2024	BUY Exercise of conversion of derivative security	-	29,500 Added 40.45%	43,436 Common Stock
Aug 01 2023	SELL Open market or private sale	$205,856 $57.23 p/Share	3,597 Reduced 20.52%	13,936 Common Stock
Aug 01 2023	BUY Exercise of conversion of derivative security	$15,539 $4.32 p/Share	3,597 Added 17.02%	17,533 Common Stock
Jul 03 2023	SELL Open market or private sale	$205,172 $57.04 p/Share	3,597 Reduced 20.52%	13,936 Common Stock
Jul 03 2023	BUY Exercise of conversion of derivative security	$15,539 $4.32 p/Share	3,597 Added 17.02%	17,533 Common Stock
Jun 12 2023	SELL Open market or private sale	$52,928 $63.01 p/Share	840 Reduced 5.68%	13,936 Common Stock
Jun 12 2023	BUY Exercise of conversion of derivative security	$3,628 $4.32 p/Share	840 Added 5.38%	14,776 Common Stock
Jun 01 2023	SELL Open market or private sale	$205,676 $57.18 p/Share	3,597 Reduced 20.52%	13,936 Common Stock
Jun 01 2023	BUY Exercise of conversion of derivative security	$15,539 $4.32 p/Share	3,597 Added 17.02%	17,533 Common Stock
May 03 2023	SELL Open market or private sale	$183,842 $51.11 p/Share	3,597 Reduced 20.52%	13,936 Common Stock
May 03 2023	BUY Exercise of conversion of derivative security	$15,539 $4.32 p/Share	3,597 Added 17.02%	17,533 Common Stock
Apr 25 2023	SELL Open market or private sale	$1,344,558 $53.4 p/Share	25,179 Reduced 64.37%	13,936 Common Stock
Apr 25 2023	BUY Exercise of conversion of derivative security	$108,773 $4.32 p/Share	25,179 Added 39.16%	39,115 Common Stock
Jan 14 2023	SELL Open market or private sale	$123,347 $30.63 p/Share	4,027 Reduced 24.11%	12,679 Common Stock
Jan 14 2023	BUY Exercise of conversion of derivative security	-	12,500 Added 42.8%	16,706 Common Stock
Feb 02 2021	SELL Open market or private sale	$431,103 $36.13 p/Share	11,932 Reduced 78.41%	3,286 Common Stock
Feb 02 2021	BUY Exercise of conversion of derivative security	$51,546 $4.32 p/Share	11,932 Added 43.95%	15,218 Common Stock
Feb 01 2021	SELL Open market or private sale	$135,840 $33.96 p/Share	4,000 Reduced 54.9%	3,286 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	$17,280 $4.32 p/Share	4,000 Added 35.44%	7,286 Common Stock
Jan 05 2021	SELL Open market or private sale	$52,086 $31.51 p/Share	1,653 Reduced 30.24%	3,813 Common Stock

Also insider at

AVRO

AVROBIO, Inc. Healthcare

PPT